Medium chain triglycerides (MCTs) improved cognition in patients with Alzheimer's disease.
“After completing both forms of the intervention, all the participants received MCTs for six months. The investigators collected the participants' demographic and health data, which included measures of blood lipids, fasting insulin, body mass index, and body fat composition.”